BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 21436157)

  • 1. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
    Kaneko H; Anzai T; Takahashi T; Kohno T; Shimoda M; Sasaki A; Shimizu H; Nagai T; Maekawa Y; Yoshimura K; Aoki H; Yoshikawa T; Okada Y; Yozu R; Ogawa S; Fukuda K
    Cardiovasc Res; 2011 Jul; 91(2):358-67. PubMed ID: 21436157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption.
    Watanabe A; Ichiki T; Sankoda C; Takahara Y; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K
    Clin Sci (Lond); 2014 May; 126(9):671-8. PubMed ID: 24256203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.
    Kaneko H; Anzai T; Horiuchi K; Kohno T; Nagai T; Anzai A; Takahashi T; Sasaki A; Shimoda M; Maekawa Y; Shimizu H; Yoshikawa T; Okada Y; Yozu R; Fukuda K
    Atherosclerosis; 2011 Oct; 218(2):470-8. PubMed ID: 21722904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm.
    Tazume H; Miyata K; Tian Z; Endo M; Horiguchi H; Takahashi O; Horio E; Tsukano H; Kadomatsu T; Nakashima Y; Kunitomo R; Kaneko Y; Moriyama S; Sakaguchi H; Okamoto K; Hara M; Yoshinaga T; Yoshimura K; Aoki H; Araki K; Hao H; Kawasuji M; Oike Y
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1400-9. PubMed ID: 22556334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-Bound Thrombomodulin Regulates Macrophage Inflammation in Abdominal Aortic Aneurysm.
    Wang KC; Li YH; Shi GY; Tsai HW; Luo CY; Cheng MH; Ma CY; Hsu YY; Cheng TL; Chang BI; Lai CH; Wu HL
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2412-22. PubMed ID: 26338301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of development of abdominal aortic aneurysm by glycolysis restriction.
    Tsuruda T; Hatakeyama K; Nagamachi S; Sekita Y; Sakamoto S; Endo GJ; Nishimura M; Matsuyama M; Yoshimura K; Sato Y; Onitsuka T; Imamura T; Asada Y; Kitamura K
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1410-7. PubMed ID: 22499992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Lung Inflammation Aggravates Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice.
    Liu CL; Wang Y; Liao M; Wemmelund H; Ren J; Fernandes C; Zhou Y; Sukhova GK; Lindholt JS; Johnsen SP; Zhang JY; Cheng X; Huang X; Daugherty A; Levy BD; Libby P; Shi GP
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):69-77. PubMed ID: 26543094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
    Kurobe H; Matsuoka Y; Hirata Y; Sugasawa N; Maxfield MW; Sata M; Kitagawa T
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1501-8. PubMed ID: 23535154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
    Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.
    Nakao T; Horie T; Baba O; Nishiga M; Nishino T; Izuhara M; Kuwabara Y; Nishi H; Usami S; Nakazeki F; Ide Y; Koyama S; Kimura M; Sowa N; Ohno S; Aoki H; Hasegawa K; Sakamoto K; Minatoya K; Kimura T; Ono K
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2161-2170. PubMed ID: 28882868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
    Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
    J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel rat model of abdominal aortic aneurysm using a combination of intraluminal elastase infusion and extraluminal calcium chloride exposure.
    Tanaka A; Hasegawa T; Chen Z; Okita Y; Okada K
    J Vasc Surg; 2009 Dec; 50(6):1423-32. PubMed ID: 19958989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation.
    Saito T; Hasegawa Y; Ishigaki Y; Yamada T; Gao J; Imai J; Uno K; Kaneko K; Ogihara T; Shimosawa T; Asano T; Fujita T; Oka Y; Katagiri H
    Cardiovasc Res; 2013 Jan; 97(1):106-14. PubMed ID: 23015640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.
    Ji K; Zhang Y; Jiang F; Qian L; Guo H; Hu J; Liao L; Tang J
    J Vasc Surg; 2014 Feb; 59(2):492-9. PubMed ID: 23676189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation.
    Liu Z; Fitzgerald M; Meisinger T; Batra R; Suh M; Greene H; Penrice AJ; Sun L; Baxter BT; Xiong W
    Cardiovasc Res; 2019 Mar; 115(4):807-818. PubMed ID: 30428004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.
    Dale MA; Suh MK; Zhao S; Meisinger T; Gu L; Swier VJ; Agrawal DK; Greiner TC; Carson JS; Baxter BT; Xiong W
    Atherosclerosis; 2015 Dec; 243(2):621-9. PubMed ID: 26546710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
    Wang W; Xu B; Xuan H; Ge Y; Wang Y; Wang L; Huang J; Fu W; Michie SA; Dalman RL
    J Vasc Surg; 2018 Nov; 68(5):1538-1550.e2. PubMed ID: 29242064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.